Introduction {#section1-1533033819887962}
============

Pancreatic cancer (PC) is a common lethal human gastrointestinal cancer with a 1-year survival rate of only ∼10% and a 5-year survival rate of ∼ 8% due to the poor prognosis, frequent recurrence, metastasis, and absence of effective therapies.^[@bibr1-1533033819887962],[@bibr2-1533033819887962]^ It is estimated that there are about 55 440 new cases of PC in the United States in 2018, including 26 240 female patients and 29 200 male patients.^[@bibr3-1533033819887962]^ Unlike other gastrointestinal cancers, radiotherapy, chemotherapy, and targeted therapies hardly improve the survival of patients with PC.^[@bibr4-1533033819887962]^ Therefore, it is urgent to explore new therapeutic targets for PC. Until now, a lot of molecular mechanisms involved in PC progression have been explored, but the potential networks between long non-coding RNA (lncRNA) and microRNA (miRNA) remain deficiently investigated.

Long noncoding RNAs are longer than 200 nucleotides with no protein-coding potential and cannot be translated into proteins.^[@bibr5-1533033819887962]^ Accumulating evidences show that lncRNAs are involved in different kinds of cancers, serving as critical regulators of cancer origination, progression, and metastasis, and many of them were the promising prognostic markers.^[@bibr6-1533033819887962]^ Importantly, lncRNAs play a crucial part in the pathogenesis, diagnosis, treatment, and prognosis of PC.^[@bibr7-1533033819887962]^ For example, Lian *et al* found that lncRNA-HOXA-AS2--EZH2--LSD1 complex might promote PC cell proliferation as an oncogene.^[@bibr8-1533033819887962]^ It was showed that upregulation of lncRNA GHET1,^[@bibr9-1533033819887962]^ PVT1,^[@bibr10-1533033819887962]^ TUG1/EZH2,^[@bibr11-1533033819887962]^ HNF1A/CASC2,^[@bibr12-1533033819887962]^ and SNHG15^[@bibr13-1533033819887962]^ could promote the proliferation of PC cells.^[@bibr14-1533033819887962]^ Besides, CRNDE,^[@bibr15-1533033819887962]^ NORD,^[@bibr16-1533033819887962]^ and GAS5^[@bibr17-1533033819887962]^ were proved to be related to malignancy and distant metastasis in PC.

The long noncoding RNA BRAF-activated noncoding RNA (BANCR), 693-bp in length and located on chromosome 9, was found in 2012 by Flockhart *et al*.^[@bibr18-1533033819887962]^ Numerous studies had shown that BANCR was upregulated in melanoma and related to cell proliferation, migration, and invasion.^[@bibr19-1533033819887962][@bibr20-1533033819887962]-[@bibr21-1533033819887962]^ Furthermore, dysregulated BANCR was involved in various types of human diseases, particularly in malignant diseases such as gastric cancer, lung cancer, colorectal cancer, melanoma, thyroid cancer, osteosarcoma, retinoblastoma, and hepatocellular carcinoma.^[@bibr22-1533033819887962]^ But the expression patterns and functions of BANCR in PC are rarely known.

In our present work, we aim to examine the roles and underlying mechanisms of BANCR in PC. The results indicated that the expression of BANCR was upregulated in PC, and knockdown of BANCR restrained cell survival and invasion *in vitro*. Moreover, our study further revealed that BANCR directly binds to miR-195-5p and therefore inhibited its expression. Further studies demonstrated that BANCR regulates PC cell growth and metastasis through miR-195-5p/Wnt/β-catenin axis. Collectively, our study showed that BANCR may serve as a potential target for diagnostics and therapeutics in PC.

Materials and Methods {#section2-1533033819887962}
=====================

Patient Data and Tissues Collection {#section3-1533033819887962}
-----------------------------------

The PC tissues and adjacent healthy tissues were obtained from 45 patients with PC who were subjected surgical resection in The First Affiliated Hospital of Nanjing Medical University from January 2015 to December 2017. This study was approved by the Ethics Committee of The First Affiliated Hospital of Nanjing Medical University, and all patients had signed written informed consent before performing this study. In addition, the clinical features of patients with PC are summarized in [Table 1](#table1-1533033819887962){ref-type="table"}.

###### 

Summary of the Clinical Characteristics.

![](10.1177_1533033819887962-table1)

  Characteristics         Number of Patients
  ----------------------- --------------------
  Total cases             45
  Age                     62.7 ± 10.2
  Gender                  
   Male                   26
   Female                 19
  TNM (AJCC)              
   I                      12
   Ⅱ                      8
   Ⅲ                      10
   Ⅳ                      15
  Lymph node metastasis   
   Negative               18
   Positive               27
  Histological            
   Well                   27
   Moderate               11
   Poor                   7

Abbreviations: TNM, tumor--node--metastasis; AJCC, American Joint Committee on Cancer.

Cell Lines and Culture Conditions {#section4-1533033819887962}
---------------------------------

Human pancreatic ductal cell line (HPNE) and PC cell lines, including PANC-1, SW1990, HS766T, and CFPAC-1, were purchased from BeNa Culture Collection (Beijing, China) and cultured in incubator with 100% humidity and 5% CO~2~ at 37°C. The HPNE cells were grown in Dulbecco modified Eagle medium (DMEM; Sigma, St Louis, Missouri) containing 1 volume of M3 Base F culture medium (InCell Corp, San Antonio, Texas), 3 volumes of glucose-free DMEM, 10% fetal bovine serum (FBS; (Invitrogen, Carlsbad, California), 5.5 mM glucose, 10 ng/mL epidermal growth factor (EGF), and 50 µg/mL gentamycin. The DMEM medium with 10% FBS was applied to culture PANC-1 and HS766T cells. SW1990 cells were maintained in Leibovitz L-15 Medium (Sigma). Furthermore, CFPAC-1 cells were cultured in Iscove Modified Dulbecco Medium (Sigma) adding 10% FBS.

Total RNAs Extraction and Quantitative Real-Time Polymerase Chain Reaction Analysis {#section5-1533033819887962}
-----------------------------------------------------------------------------------

Total RNAs were extracted from tissue samples or cell lines using TRIzol reagent (Invitrogen). After disposed with DNase I (DNA-free kit, Ambion, Austin, Texas), reverse transcription was conducted to transcribe the isolated RNA into complementary DNA (cDNA) with the reverse transcriptase (Takara, Dalian, China) using the stem-loop RT primer. Next, the RT products (cDNA) were amplified using SYBR Green real-time polymerase chain reaction (RT-PCR; Takara). The levels of miR-195-5p quantified by quantitative RT-PCR were standardized to that of U6. BRAF-activated noncoding RNA were also analyzed using SYBR Green RT-PCR. The relative BANCR expression was normalized to control values of reference gene glyceraldehyde-3-phosphate dehydrogenase (GAPDH). All the primers used for qRT-PCR in this study are presented in [Table 2](#table2-1533033819887962){ref-type="table"}.

###### 

Primer Sequences Used in this Study.

![](10.1177_1533033819887962-table2)

  Primer Name and Primer Sequences
  -----------------------------------------------------------
  Stem-loop primer for miR-195-5p
   RT: 5′-CTCAACTGGTGTCGTGGAGTCGGCAATTCAGTTGA  GGCCAATAT-3′
   Stem-loop primer for U6: 5′-CTCGCTTCGGCAGCACA-3′
  Primers for real-time PCR
   BANCR sense: 5′-ACAGGACTCCATGGCAAACG-3′
   BANCR antisense: 5′-ATGAAGAAAGCCTGGTGCAGT-3′
   miR-195-5p sense: 5′-ACACTCCAGCTGGGTAGCAGCACAG  AAAT-3′
   miR-195-5p antisense: 5′-TGGTGTCGTGGAGTCG-3′
   U6 sense: 5′-CTCGCTTCGGCAGCACA-3′
   U6 antisense: 5′-AACGCTTCACGAATTTGCGT-3′
   GAPDH sense: 5′-GAAGGTGAAGGTCGGAGTC-3′
   GAPDH antisense: 5′-GAAGATGGTGATGGGATTTC-3′

Abbreviations: BANCR, BRAF-activated noncoding RNA; PCR, polymerase chain reaction; GAPDH, glyceraldehyde-3-phosphate dehydrogenase.

Cells Transfection *In Vitro* {#section6-1533033819887962}
-----------------------------

MiR-195-5p mimics, inhibitor, short-interfering RNAs (siRNA) targeting BANCR, and their corresponding negative control (si-NC and miR-NC) were all purchased from Ribobio (Guangzhou, China). The sequence of miR-mimics was 5′-UAGCAGCACAGAAAUAUUGGC-3′. The sequences of miR-inhibitor were 5′-GCCAAUAUUUCUGUGCUGCUA-3′ and 5′-UUCUCCGAACGUGUCACGUTT-3′ for miR-NC. The sequences of si-BANCR1 were 5′-GCUGAGAAGUUCAGAGUCAAA-3′ (sense) and 5′-UGACUCUGAACUUCUCAGCAG-3′ (antisense). The sequences of si-BANCR2 were 5′-GGCUGCUGCUCAGAAGAAACA-3′ (sense) and 5′-UUUCUUCUGAGCAGCAGCCAG-3′ (antisense) and 5′-UUCACCGAUCGUGACGCGUTT-3′ (sense) and 5′-ACGAGUCACGTUCGGAGACTT-3′ (antisense) for si-NC. Before transfection, PANC-1 and SW1990 cells were cultured until 60% confluent and then washed with phosphate-buffered saline (PBS). Next, mimics and inhibitors were transfected into PANC-1 and SW1990 cells using lipofectamine 3000 transfection reagent (Invitrogen), while siRNAs were transfected into PANC-1 and SW1990 using Lipofectamine RNAiMAX (Invitrogen) in the light of the manufacturer's recommended protocol, and 50 nM of mimic and inhibitor or 40 nM of siRNA was transfected for 48 hours.

MTT and Colony Formation Assay {#section7-1533033819887962}
------------------------------

3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2-H-tetrazolium bromide (MTT) assay was conducted to determine cell viability. Briefly, PANC-1 and SW1990 cells transfected with si-NC, si-BANCR1, si-BANCR2, miR-NC, and miR-inhibitor or cotransfected with si-BANCR1 + miR-inhibitor were put into 96-well plates, and 200 μL complete medium was added. After a period of incubation, each well was added 20 μL MTT (5 mg/mL) and terminated culture 4 hours later. After abandoning the supernatant, 150 μL of dimethyl sulfoxide was added, and the optical density value at 570 nm was measured. For the colony formation assay, the transfected cells were placed in a 6-well plate and maintained in DMEM medium at 37°C and 5% CO~2~ atmosphere condition. Ten days later, the cells were stained with GIMSA for 20 minutes after fixing with paraformaldehyde. Visible colonies were manually counted microscopically based on 5 random fields. Triplicate wells were measured in each treatment group.

Cell Invasion and Migration Assays {#section8-1533033819887962}
----------------------------------

To assess cell invasion, 4 × 10^4^ transfected cells in 200 µL serum-free medium were put into the upper chamber coated with diluted Matrigel (1:8) (Corning Life Sciences, Tewksbury, MA, USA), and 500 µL complete medium was added into the lower chamber. Cells were washed by PBS twice and fixed with paraformaldehyde for 25 minutes and stained with 0.1% Crystal violet for 35 minutes after culturing for 36 hours. Then, pictures were taken under a light microscope. As for migration assays, the collected cells were washed twice by PBS and mixed with 1% serum-free medium. Next, 5 × 10^4^ cells in the chamber were cultured for 24 hours, and then they were fixed with methanol before staining with 0.1% Crystal violet. Each chamber was photographed in 5 random fields and numbered.

Luciferase Reporter Assays {#section9-1533033819887962}
--------------------------

After culturing for 24 hours, 293T cells were co-transfected with BANCR 3′-untranslated region and cloned into the psiCHECK-2 vector and miR-mimics or NC mimics (100 ng/well) using Lipofectamine 3000 (Invitrogen). After 48 hours, the cells were washed using PBS and then lysed with passive lysis buffer at room temperature for 20 minutes. The incubation lysates were collected and transferred to 96-well plates, and the aliquots were added to the plates. The firefly luciferase activity was measured in the Infinite M200 plate reader (Tecan, Männedorf, Switzerland) system after adding Luciferase Assay Reagent II immediately. Next, the Stop & Glo reagent was used to initiate the Renilla luciferase. The relative luciferase activity for miRNA-195-5p is shown relative to the NC mimics.

RNA Immunoprecipitation Based on Ago2 {#section10-1533033819887962}
-------------------------------------

PANC-1 and SW1990 cells transfected with NC mimics or miR-mimics were cultured for 48 hours. Next, the cells were collected. respectively, and RNA immunoprecipitation (RIP) assay was implied to confirm the association of BANCR and miR-195-5p using an anti-Ago2 antibody (Millipore) in the light of the manufacturer's instructions. Then, RNAs obtained from the RIP products were used to performed RT-PCR to examine the enrichment of BANCR, and miR-195-5p. Immunoglobulin G (Millipore, Bedford, MA, USA) served as the negative control.

Western Blots {#section11-1533033819887962}
-------------

Transfected PANC-1 and SW1990 cells were treated with or without XAV939, and the cells were lysed in ice-cold RIPA Buffer (Cell Signaling Technology, Beverly, MA, USA) with protease inhibitor cocktail (Roche, Switzerland) and incubated for 30 minutes on ice. Sodium dodecyl sulfate polyacrylamide gel electrophoresis was performed in 10% to 15% Tris-Glycine Gels, and then the separated proteins were transferred to polyvinyldifluoride membranes (Millipore). The membranes were blocked with 0.05% Tween-20 and 5% milk in Tris-buffered saline, incubated with primary antibodies, and washed on the basis of standard procedures. Primary antibodies were rabbit monoclonal anti-β-catenin (1:1000, ab32572; Abcam, Cambridge, MA, USA), rabbit monoclonal anti-c-Myc (1:1000, ab168727; Abcam), rabbit monoclonal anti-cyclinD1 (1:1000, ab16663; Abcam), rabbit polyclonal anti-Ago2 (1:1000, ab32381; Abcam), and rabbit monoclonal anti-GAPDH (1:1000, ab9485; Abcam). After incubation with the HRP-conjugated antibody, immunoreactive protein bands were washed with PBS Tween-20 and detected using Amersham ECLTM detection reagents (GE Healthcare, Uppsala, Sweden) and the Odyssey scanning system (LI-COR, Lincoln, NE, USA).

Statistical Analyses {#section12-1533033819887962}
--------------------

Data are expressed as the mean ± standard deviation. We evaluated the data by GraphPad Prism version 6 (San Diego, California), and Student *t* test or 1-way analysis of variance was used appropriately. The differences at *P* \< .05 were deemed to be statistically significant.

Results {#section13-1533033819887962}
=======

BRAF-Activated Noncoding RNA was Upregulated in PC Tissues and Cell Lines {#section14-1533033819887962}
-------------------------------------------------------------------------

The expression levels of BANCR in the tumors and adjacent healthy tissues of 45 patients with PC were measured by qRT-PCR. Detailed information for these 45 patients is listed in [Table 1](#table1-1533033819887962){ref-type="table"}. Data show that BANCR level was higher in PC tissues than that in the corresponding healthy tissues ([Figure 1A](#fig1-1533033819887962){ref-type="fig"}). As shown in [Figure 1B](#fig1-1533033819887962){ref-type="fig"}, [a](#fig1-1533033819887962){ref-type="fig"} statistical difference in BANCR level was present between the nonmetastatic (n = 18) and metastatic tissue samples (n = 27). Meanwhile, tumor--node--metastasis (TNM) stage (stage I, II, III, and Ⅳ) was positively associated with elevated BANCR expression ([Figure 1C](#fig1-1533033819887962){ref-type="fig"}). The expression of BANCR in PANC-1, SW1990, HS766T, and CFPAC-1 cells (PC cell lines) and in HPNE cells was detected, and we found that the level of BANCR was elevated in the PC cell lines compared to that in HPNE cells ([Figure 1D](#fig1-1533033819887962){ref-type="fig"}), especially in PANC-1 and SW1990 cells; therefore, PANC-1 and SW1990 were selected as the main experimental cells. The abovementioned data indicate that induced BANCR expression was upregulated in PC.

![BRAF-activated noncoding RNA is significantly upregulated in PC tissues and cell lines. (A) Relative expression of BANCR in PC tissues (n = 45) and adjacent healthy tissues (n = 45) was analyzed by qRT-PCR. (\*\*\**P* \< .01). (B) Relative expression of BANCR in PC tissues from patients with metastasis (n = 27) and from patients without metastasis (n = 18; \*\*\**P* \< .01). (C) Relative expression of BANCR in PC tissues from patients with different clinical stages (stage I: n = 12; stage II: n = 8; stage III: n = 10; stage IV: n = 15; \**P* \< .05, \*\**P* \< .01, and \*\*\**P* \< .001 vs stage I group). (D) Relative expression of BANCR in human pancreatic ductal cell (HPNE) and PC cell lines (PANC-1, SW1990, HS766T, and CFPAC-1). \*\**P* \< .01 and \*\*\**P* \< .001 versus HPNE group. BANCR indicates RNA BRAF-activated noncoding RNA; PC, pancreatic cancer; qRT-PCR, quantitative real-time polymerase chain reaction.](10.1177_1533033819887962-fig1){#fig1-1533033819887962}

Knockdown of BANCR Inhibited PC Cell Proliferation, Invasion, and Migration {#section15-1533033819887962}
---------------------------------------------------------------------------

To determine the effects of BANCR on PC cells, special siRNAs were used to knockdown BANCR expression in PC cells (including PANC-1 and SW1990 cell lines). The transfection efficiency was determined by qRT-PCR, finding that si-BANCR1 and si-BANCR2 effectively downregulated BANCR levels both in PANC-1 and SW1990 cell lines ([Figure 2A](#fig2-1533033819887962){ref-type="fig"}). By performing MTT assays, we found that BANCR downregulation could significantly decrease the viability of PANC-1 and SW1990 cells compared to parallel cell lines transfected with scramble siRNA (si-NC cells; [Figure 2B and C](#fig2-1533033819887962){ref-type="fig"}). The colony formation assay results showed that the colony numbers in si-BANCR1 and si-BANCR2 group cells were obviously lower than those in NC groups ([Figure 2D](#fig2-1533033819887962){ref-type="fig"}). Transwell assay was used to quantitatively assess PC cell invasion and migration. Compared to the si-NC groups, the number of invading PANC-1 and SW1990 cells in the si-BANCR1 and si-BANCR2 groups were largely reduced ([Figure 2E](#fig2-1533033819887962){ref-type="fig"}). As expected, si-BANCR1 and si-BANCR2 groups show less migratory cells than that in si-NC groups ([Figure 2F](#fig2-1533033819887962){ref-type="fig"}). These findings collectively suggested that knockdown of BANCR inhibited PC cell proliferation and metastasis.

![BRAF-activated noncoding RNA knockdown significantly inhibits PC cell proliferation, invasion, and migration. (A) PANC-1 and SW1990 cells were transfected with si-BANCR1, si-BANCR2, or their negative controls (si-NC). The relative BANCR levels were determined by qRT-PCR following 48 hours of culture. (B) and (C) MTT assay was used to detect the cell viability of si-BANCR-transfected PANC-1 and SW1990 cells. (D) Colony formation assay was performed to clarify the cell proliferation of PANC-1 and SW1990 cells. (E) Transwell assay was used to detect the invasion capacity in PANC-1 and SW1990 cells. (F) Transwell assay was used to detect the migration capacity in PANC-1 and SW1990 cells. \**P* \< .05 and \*\**P* \< .01 compared to si-NC group. BANCR indicates BRAF-activated noncoding RNA; PC, pancreatic cancer; qRT-PCR, quantitative real-time polymerase chain reaction.](10.1177_1533033819887962-fig2){#fig2-1533033819887962}

BRAF-Activated Noncoding RNA Functions as a Sponge for miR-195-5p in PC {#section16-1533033819887962}
-----------------------------------------------------------------------

Accumulative evidence has demonstrated that lncRNAs can directly mediate miRNAs by functioning as competing endogenous RNAs (ceRNAs).^[@bibr23-1533033819887962],[@bibr24-1533033819887962]^ To identify BANCR that may interact with miRNAs, the bioinformatics software starBase version 2.0 was utilized to search for miRNAs that contained a binding site with BANCR. We found that miR-195-5p, a known tumor suppressor,^[@bibr25-1533033819887962],[@bibr26-1533033819887962]^ exhibited a binding site for BANCR ([Figure 3A](#fig3-1533033819887962){ref-type="fig"}). Expression of miR-195-5p was remarkably decreased in PC tissues compared to that in healthy tissues, as detected by qRT-PCR ([Figure 3B](#fig3-1533033819887962){ref-type="fig"}). In addition, the levels of miR-195-5p were strikingly decreased in PC cell lines (PANC-1, SW1990, HS766T, and CFPAC-1) compared to that in HPNE ([Figure 3C](#fig3-1533033819887962){ref-type="fig"}). Next, the correlation between expression of BANCR and miR-195-5p was analyzed. The results showed that BANCR was negatively correlated with miR-195-5p expression ([Figure 3D](#fig3-1533033819887962){ref-type="fig"}).

![BRAF-activated noncoding RNA directly targets miR-195-5p. (A) The predicated miR-195-5p binding site of BANCR (CCAT1-Wt) and the designed BANCR-Mut are indicated. (B) Relative expression of miR-195-5p in PC tissues and adjacent healthy tissues was analyzed by qRT-PCR (n = 45, \*\**P* \< .01). (C) Relative expression of miR-195-5p in PC cell lines and HPNE cells was measured by qRT-PCR. The level of relative miR-195-5p expression was decreased in 4 PC cell lines, PANC-1, SW1990, HS766T, and CFPAC-1, compared to HPNE. \**P* \< .05 and \*\**P* \< .01 versus HPNE group. (D) MiR-195-5p was negatively correlated with BANCR expression. (E) Luciferase assay was used to verify the binding between miR-195-5p and BANCR. \*\**P* \< .01 versus miR-NC group. (F-G) Endogenous BANCR pulldown by Ago2 upon overexpression of miR-195-5p was determined using RIP assays. \*\**P* \< .01 versus miR-NC group. (H-I) PANC-1 and SW1990 cells were transfected with si-BANCR1 and si-BANCR2; the expression of miR-195-5p was examined using qRT-PCR. \*\**P* \< .01 and \*\*\**P* \< .001 versus si-NC group. BANCR indicates BRAF-activated noncoding RNA; PC, pancreatic cancer; qRT-PCR, quantitative real-time polymerase chain reaction.](10.1177_1533033819887962-fig3){#fig3-1533033819887962}

To investigate the effects of BANCR on miR-195-5p expression, 293T cells were transfected with the luciferase reporter plasmid pGL3.0-BANCR and miR-195-5p. Results showed that miR-195-5p could decrease the luciferase activity of BANCR, but it shows nonsignificant effect on the mutated form of BANCR ([Figure 3E](#fig3-1533033819887962){ref-type="fig"}). Furthermore, we performed RIP assays using Ago2 antibody in PANC-1 and SW1990 cells. As expected, the endogenous levels of BANCR and miR-195-5p pulldown by Ago2 were much higher in miR-195-5p mimics groups than those in NC mimics groups ([Figure 3F and G](#fig3-1533033819887962){ref-type="fig"}). In addition, the miR-195-5p expression level was decreased in the PANC-1 and SW1990 cells treated with si-BANCR1 and si-BANCR2 ([Figure 3H and I](#fig3-1533033819887962){ref-type="fig"}). These results indicated that BANCR may interact with miR-195-5p by this putative binding site.

BRAF-Activated Noncoding RNA Promoted PC Cell Proliferation, Invasion, and Migration Through Sponging miR-195-5p {#section17-1533033819887962}
----------------------------------------------------------------------------------------------------------------

To investigate whether miR-195-5p could rescue si-BANCR-regulated proliferation and metastasis on PC cells, PANC-1 and SW1990 cells were treated with the following combinations: miR-NC; miR-inhibitor; siBANCR1 or miR-inhibitor + siBANCR1. The expression of BANCR and miR-195-5p was confirmed by qRT-PCR ([Figure 4A and B](#fig4-1533033819887962){ref-type="fig"}). As shown in [Figure 4C and D](#fig4-1533033819887962){ref-type="fig"}, inhibition of miR-195-5p vigorously promoted cell viability, and si-BANCR obviously decreased cell viability; however, the effect of miR-195-5p inhibitor was alleviated by si-BANCR. In addition, cells treated with miR-195-5p inhibitor had more colonies in PANC-1 and SW1990 cells compared to the miR-NC groups, but this effect was rescued by si-BANCR1 ([Figure 4E](#fig4-1533033819887962){ref-type="fig"}). Similarly, miR-195-5p inhibitor abrogated the effect of si-BANCR1 on cell survival and invasion ([Figure 4F and G](#fig4-1533033819887962){ref-type="fig"}). These observations revealed that BANCR could promote PC cells proliferation and metastasis by sponging miR-195-5p, decreasing miR-195-5p expression.

![BRAF-activated noncoding RNA promotes PC cell proliferation, invasion, and migration via the inhibition of miR-195-5p in pancreatic cancer. Both PANC-1 and SW1990 cells were transfected with miR-NC, miR-195-5p inhibitor, si-BANCR, and miR-195-5p inhibitor + si-BANCR. (A) and (B) Relative expression of BANCR and miR-195-5p was determined by qRT-PCR after treatment. (C) and (D) Cell viability was measured in PANC-1 and SW1990 cells using MTT assay. (E) The proliferation capacity of PANC-1 and SW1990 cells was examined using colony formation assay. (F-G) Cells invasion (G) and migration (H) were measured using Transwell assay, respectively. \**P* \< .05 and \*\**P* \< .01 versus control group; ^\#^ *P* \< .05 and ^\#\#^ *P* \< .01 versus si-BANCR group. BANCR indicates BRAF-activated noncoding RNA; PC, pancreatic cancer; qRT-PCR, quantitative real-time polymerase chain reaction.](10.1177_1533033819887962-fig4){#fig4-1533033819887962}

BRAF-Activated Noncoding RNA Regulated Wnt/β-Catenin Pathway by Sponging miR-195-5p in PC cells {#section18-1533033819887962}
-----------------------------------------------------------------------------------------------

Wnt/β-catenin pathway plays an important role in PC development and progression, and the previous study reported that miR-195-5p could suppress Wnt/β-catenin signaling pathway to regulate hair follicle inductivity in dermal papilla cells.^[@bibr27-1533033819887962]^ We further explored whether Wnt/β-catenin signaling was involved in BANCR/miR-195-5p modulating PC cell proliferation and metastasis. As shown in [Figure 5A and B](#fig5-1533033819887962){ref-type="fig"}, the expressions of β-catenin, c-Myc, and cyclinD1 were upregulated in PC cells treated with miR-195-5p inhibitor and downregulated in si-BANCR treatment group; additionally, the effects of miR-195-5p inhibitor on Wnt/β-catenin signaling were partially attenuated by si-BANCR.

![MiR-195-5p regulates Wnt/β-catenin signaling pathway in PC cells. The protein levels of β-catenin, c-Myc, and cyclinD1 were examined using Western blot analysis. (A) and (B) PANC-1 and SW1990 cells were treatment with miR-NC, miR-195-5p inhibitor, and miR-195-5p inhibitor + si-BANCR. \**P* \< .05 and \*\**P* \< .01 vs miR NC group; ^\#\#^ *P* \< .01 versus si-NC group; ^\$^ *P* \< .01 versus si-BANCR1 group (C and D) PANC-1 and SW1990 cells were treated with miR-NC, miR-195-5p inhibitor, XAV939, and miR-195-5p inhibitor + XAV939. \**P* \< .05 and \*\**P* \< .01 versus miR NC group; ^\#\#^ *P* \< .01 versus control group; ^\$^ *P* \< .01 versus XAV939 group. BANCR indicates BRAF-activated noncoding RNA; PC, pancreatic cancer; qRT-PCR, quantitative real-time polymerase chain reaction.](10.1177_1533033819887962-fig5){#fig5-1533033819887962}

The Wnt inhibitor XAV939 suppressed Wnt/β-catenin signaling and relieved the roles of miR-195-5p inhibitor and decreased the levels of β-catenin, c-Myc, and cyclinD1([Figure 5C and D](#fig5-1533033819887962){ref-type="fig"}). The Western blot assay showed that BANCR overexpression led to the increase in protein levels of β-catenin, c-Myc, and cyclinD1, and XAV939 alleviated the effects of BANCR overexpression on Wnt/β-catenin signaling pathway ([Figure 6A and B](#fig6-1533033819887962){ref-type="fig"}). These findings suggested that BANCR/miR-195-5p modulates PC cell proliferation and metastasis possibly through Wnt/β-catenin signaling.

![BANCR regulates Wnt/β-catenin signaling pathway in PC cells. The protein levels of β-catenin, c-Myc, and cyclinD1 were examined using Western blot analysis. (A and B) PANC-1 and SW1990 cells were treated with BANCR overexpression NC, BANCR overexpression, XAV939, and BANCR overexpression + XAV939. \**P* \< .05 and \*\**P* \< .01 vs BANCR-NC group; ^\#\#^ *P* \< .01 vs control group; ^\$^ *P* \< .01 vs XAV939 group. BANCR indicates long non-coding RNA BRAF-activated noncoding RNA; NC, negative control; PC, pancreatic cancer; qRT-PCR, quantitative real-time polymerase chain reaction.](10.1177_1533033819887962-fig6){#fig6-1533033819887962}

Discussion {#section19-1533033819887962}
==========

Recently, increasing evidence has identified that lncRNAs play vital roles in mediating complex cellular processes, particularly in malignant tumors, and this has drawn great attention from many researchers hoping to reveal the underlying mechanisms.^[@bibr28-1533033819887962],[@bibr29-1533033819887962]^ In this study, we identified that BANCR was markedly upregulated in PC tissues and cell lines. We also discovered that BANCR expression was positively related to tumor stage and metastasis. Moreover, inhibition of BANCR *in vitro* by si-BANCR strikingly inhibited cell proliferation, invasion, and migration by sponging the miR-195-5p, possibly via mediating Wnt/β-catenin signaling pathway. In summary, our data suggested that BANCR played a crucial role in the tumorigenesis and metastasis of PC.

To date, increasing numbers of lncRNAs are found to be crucial regulators of different cellular processes, especially those related to the carcinogenesis and the progression of cancer.^[@bibr30-1533033819887962][@bibr31-1533033819887962]-[@bibr32-1533033819887962]^ For instance, He *et al* reported that lncRNA UCA1 downregulation inhibited lung cancer cell proliferation and migration.^[@bibr33-1533033819887962]^ Li *et al* found that lncRNA TCF7 could suppress the growth and migration of colon cancer cell lines through inactivation of the Wnt/β-catenin signaling pathway.^[@bibr34-1533033819887962]^ Furthermore, the downexpression of lncRNA H19 conspicuously inhibited oral squamous cell carcinoma (OSCC) cell proliferation and epithelial--mesenchymal transition and induced apoptosis.^[@bibr35-1533033819887962]^ BRAF-activated noncoding RNA is a novel cancer-associated lncRNA in the genesis and occurrence of various human cancers.^[@bibr36-1533033819887962]^ BRAF-activated noncoding RNA was overexpressed in many cancers, including gastric cancer,^[@bibr19-1533033819887962]^ melanoma,^[@bibr37-1533033819887962]^ hepatocellular carcinoma,^[@bibr38-1533033819887962]^ lung cancer, and osteosarcoma.^[@bibr39-1533033819887962]^ However, there was little investigation focusing on the role and effect of BANCR in PC, and insufficient efforts have been carried out to explore the mechanism of BANCR in PC. In this study, we found that BANCR was upregulated in PC and uncovered the oncogenic function of BANCR in enhancing the proliferative and metastatic capacities of PC cells. Therefore, BANCR is a promising therapeutic target in various human cancers.

Numerous studies have shown that lncRNAs can function as ceRNA or a molecular sponge for mediating miRNAs in many cancers.^[@bibr40-1533033819887962]^ For example, Luo *et al* showed that lncRNA-NEAT1 promoted the expression of SIRT1 and activated the Wnt/β-catenin signaling pathway by sponging miR-34a in colorectal cancer.^[@bibr41-1533033819887962]^ Long noncoding RNA HOTAIR promoted gastric cancer progression through competitively binding miR-331-3p and enhancing HER2 expression.^[@bibr42-1533033819887962]^ Likewise, Ke *et al* revealed that the HOTAIR can act as a ceRNA for miR-326 to facilitate FGF1 expression in gliomas.^[@bibr43-1533033819887962]^ Although a lot of lncRNAs, such as GAS5,^[@bibr4-1533033819887962]^ H19,^[@bibr44-1533033819887962]^ ZEB2-AS1,^[@bibr45-1533033819887962]^ and CRNDE,^[@bibr15-1533033819887962]^ have been identified to act as ceRNA for miRNA to regulate the initiation and development of PC, the ability of BANCR to regulate PC through this method remains unknown. Here, investigations including luciferase activity assays, qRT-PCR, and RIP based on Ago2 experiments confirmed that BANCR functions as ceRNAs to regulate miR-195-5p. The tumor-suppressive roles of miR-195-5p have been widely recognized. Upregulation of miR-195-5p inhibited cell proliferation and invasion in cervical carcinoma through inhibiting tumor necrosis factor--signaling pathway.^[@bibr46-1533033819887962]^ In human endometrial carcinoma, long non-coding RNA PVT1 facilitated malignant cell behavior by reducing miR-195-5p expression.^[@bibr25-1533033819887962]^ The downregulation of miR-195-5p has also been observed in cancers, including osteosarcoma,^[@bibr26-1533033819887962],[@bibr47-1533033819887962]^ prostate cancer,^[@bibr48-1533033819887962]^ and gastric cancer.^[@bibr49-1533033819887962]^ Here, we found that the expression of miR-195-5p was reduced in PC tissues and cell lines. Low expression of miR-195-5p was negatively correlated with BANCR expression in PC. Downregulation of miR-195-5p effectively facilitated the proliferation, migration, and invasion of PANC-1 and SW1990 cells. Conversely, inhibition of BANCR inverted the auxo-action of miR-195-5p inhibitor on cell survival. These data suggested that BANCR acts as an oncogene by suppressing the expression of miR-195-5p in PC progression.

As previous studies reported, miR-195-5p could inhibit Wnt/β-catenin to modulate hair follicle inductivity of dermal papilla cells.^[@bibr27-1533033819887962]^ Besides, miR-195-5p suppressed renal cell carcinoma progression and alleviated sorafenib resistance via REGγ/Wnt/β-catenin.^[@bibr50-1533033819887962]^ In the present work, we further explore whether Wnt signaling is involved in BNACR/miR-195-5p-modulating PC cell proliferation and migration. Consistent with previous studies mentioned earlier, BNACR knockdown reduced the key protein expressions of Wnt/β-catenin signaling pathway, including β-catenin, c-Myc, and cyclinD1, which could be partially rescued by miR-195-5p inhibition. XAV939, the inhibitor of Wnt/β-catenin signaling pathway, was used to further explore BNACR/miR-195-5p and whether via the Wnt/β-catenin signaling pathway promotes PC development. The results indicated that XAV939 could rescue the effects of miR-195-5p inhibitor and BANCR overexpression on Wnt/β-catenin signaling pathway. Therefore, BNACR/miR-195-5p regulates PC cell proliferation and migration via downstream Wnt/β-catenin signaling pathway. Further studies are required to investigate the underlying mechanisms involved in the BANCR regulation of tumorigenesis in PC.

In conclusion, we described here that BANCR was upregulated in PC tissues and cells, and BANCR facilitated the proliferation, invasion, and migration of PC by regulating the miR-195-5p/Wnt/β-catenin signaling pathway, implicating that BANCR may be a biomarker for PC, which might provide a potential target for the diagnosis, treatment, and prognosis of PC.
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BANCR

:   BRAF-activated noncoding RNA

DMEM

:   Dulbecco modified Eagle Medium

FBS

:   fetal bovine serum

HPNE cells

:   human pancreatic ductal cell

lncRNA

:   long non-coding RNA

miRNA

:   microRNA

NC

:   negative control

PBS

:   phosphate buffered solution

PC

:   pancreatic cancer

qRT-PCR

:   quantitative real-time polymerase chain reaction

RIP

:   RNA immunoprecipitation

siRNAs

:   short-interfering RNAs
